ASPE
Aspen Neuroscience, Inc. · Healthcare
Insiders bought $68.0M net in the last 90 days ·0 sellers, 4 buyers· latest Form 4 filed Nov 4, 2026
Insider Buying
$68.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Nov 4, 2026
Thompson Peter A.
Aspen Neuroscience, Inc. (ASPE) has 6 SEC Form 4 filings (30 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Nov 4, 2026.
Inside the rolling window, 4 insiders at Aspen Neuroscience, Inc. reported 4 open-market purchases totaling $68.0M and no open-market sales. Insiders have net bought $68.0M over the trailing 6 months. The largest single insider purchase in this window was $20.0M by 10% Owner ARCH Venture Fund X, L.P. on Nov 2, 2026. The most recent open-market filing is a purchase of 1,000,000 shares by Director, 10% Owner Thompson Peter A., dated Nov 2, 2026, worth $15.0M.
- Industry:Biotechnology
- CEO:Damien McDevitt
- Employees:117
- HQ:San Diego, CA, US
- IPO:2026-10-30
| Source | |||||||
|---|---|---|---|---|---|---|---|
Thompson Peter A.First in 4 months | Director, 10% Owner | Purchase | 1,000,000 | $15.0M | Nov 4 | — | SEC ↗ |
| Director, 10% Owner | Purchase | 1,000,000 | $15.0M | Nov 4 | — | SEC ↗ | |
ARCH Venture Fund X, L.P.First filing | 10% Owner | Purchase | 1,333,333 | $20.0M | Nov 3 | — | SEC ↗ |
ARCH Venture Partners XIV, L.P.First filing | 10% Owner | Purchase | 1,200,000 | $18.0M | Nov 3 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ASPE have?
Aspen Neuroscience, Inc. (ASPE) has 6 SEC Form 4 filings (30 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Nov 4, 2026.
When was the most recent SEC Form 4 filing for ASPE?
The most recent Form 4 filing for ASPE on Tracefour is dated Nov 4, 2026.
What is the net insider flow at ASPE over the last 6 months?
Over the trailing 180 days, insiders at ASPE have net bought $68.0M based on SEC Form 4 disclosures.
What was the largest insider purchase at ASPE?
The largest single insider open-market purchase at ASPE in the rolling window was $20.0M by 10% Owner ARCH Venture Fund X, L.P. on 2026-11-02.
What is the total insider buy and sell value at ASPE in the current window?
Inside the rolling window, insiders at ASPE bought $68.0M and sold $0 based on SEC Form 4 filings.
Can I get alerts for ASPE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Aspen Neuroscience, Inc. (ASPE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Aspen Neuroscience, Inc. is in the Healthcare sector.